CoChat

i-cisTarget 2015 update: generalized cis-regulatory enrichment analysis in human, mouse and fly

Open access
Imrichová, Hana, Hulselmans, Gert, Kalender Atak, Zeynep, Potier, Delphine, Aerts, Stein · 2015 · Nucleic Acids Research

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Abstract

i-cisTarget is a web tool to predict regulators of a set of genomic regions, such as ChIP-seq peaks or co-regulated/similar enhancers. i-cisTarget can also be used to identify upstream regulators and their target enhancers starting from a set of co-expressed genes. Whereas the original version of i-cisTarget was focused on Drosophila data, the 2015 update also provides support for human and mouse data. i-cisTarget detects transcription factor motifs (position weight matrices) and experimental data tracks (e.g. from ENCODE, Roadmap Epigenomics) that are enriched in the input set of regions. As experimental data tracks we include transcription factor ChIP-seq data, histone modification ChIP-seq data and open chromatin data. The underlying processing method is based on a ranking-and-recovery procedure, allowing accurate determination of enrichment across heterogeneous datasets, while also discriminating direct from indirect target regions through a 'leading edge' analysis. We illustrate i-cisTarget on various Ewing sarcoma datasets to identify EWS-FLI1 targets starting from ChIP-seq, differential ATAC-seq, differential H3K27ac and differential gene expression data. Use of i-cisTarget is free and open to all, and there is no login requirement. Address: http://gbiomed.kuleuven.be/apps/lcb/i-cisTarget.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/nar/gkv395

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. i-cisTarget workflow. The i-cisTarget web-tool consists of two parts, namely the ranking (offline part) and recovery (online part). (a) A set of 1,223,024 candidate regulatory regions (CRRs) is defined based on publicly available regulatory data, representing 35% of the human genome. (b) The collection of CRRs is scored and ranked according to different features, including motifs, TF and histone ChIP-seq, DNase-seq and FAIRE-seq, resulting in large ranking databases. (c) The online part starts with user input, which can be a set of genomic regions or a set of genes for human, mouse or fly. (d) The input set is mapped to the candidate i-cisTarget regions. In the case of regions/peaks, the overlapping CRRs (minimum overlap percentage is a parameter) with the peaks are considered in the analysis. When a gene set is used as input, then CRRs overlapping the entire space of X kb around TSSs are taken into the analysis (the default space for human and mouse genome is 20 kb around TSS; the default for fly is 5 kb upstream of TSS and all introns). (e) The recovery analysis identifies the feature for which the input CRRs are most enriched in the top of the CRR ranking of that feature. This enrichment is calculated by the Area Under the recover Curve (AUC) and all features with normalized AUC (i.e. Normalized Enrichment Score, or NES) above 3.0 are returned. (f) For each enriched feature and upstream regulator the direct target regions are provided, with a link to a BED file for download and a track in the UCSC Genome Browser.
Figure 1. i-cisTarget workflow. The i-cisTarget web-tool consists of two parts, namely the ranking (offline part) and recovery (online part). (a) A set of 1,223,024 candidate regulatory regions (CRRs) is defined based on publicly available regulatory data, representing 35% of the human genome. (b) The collection of CRRs is scored and ranked according to different features, including motifs, TF and histone ChIP-seq, DNase-seq and FAIRE-seq, resulting in large ranking databases. (c) The online part starts with user input, which can be a set of genomic regions or a set of genes for human, mouse or fly. (d) The input set is mapped to the candidate i-cisTarget regions. In the case of regions/peaks, the overlapping CRRs (minimum overlap percentage is a parameter) with the peaks are considered in the analysis. When a gene set is used as input, then CRRs overlapping the entire space of X kb around TSSs are taken into the analysis (the default space for human and mouse genome is 20 kb around TSS; the default for fly is 5 kb upstream of TSS and all introns). (e) The recovery analysis identifies the feature for which the input CRRs are most enriched in the top of the CRR ranking of that feature. This enrichment is calculated by the Area Under the recover Curve (AUC) and all features with normalized AUC (i.e. Normalized Enrichment Score, or NES) above 3.0 are returned. (f) For each enriched feature and upstream regulator the direct target regions are provided, with a link to a BED file for download and a track in the UCSC Genome Browser.CC BY · PubMed Central
Figure 2. Ewing sarcoma case study. Various i-cisTarget analyses with different types of input, all related to EWS-FLI1 targets in Ewing sarcoma. (a) All input datasets are derived from Riggi et al. (35) and include FLI1 ChIP-seq peaks, top differentially less active peaks based on H3K27ac ChIP-seq upon EWS-FLI1 knockdown, differentially more open regions based on ATAC-seq after EWS-FLI1 activation and differentially downregulated genes after EWS-FLI1 knockdown (see ‘Materials and Methods’ section). (b) Input regions are automatically mapped to CRRs. (c). Each of the sets was analysed independently and reassuringly the expected motif EWS-FLI1 was ranked at the top, alongside regulatory tracks, mainly obtained on the SK-N-MC Ewing sarcoma cell line. Note that the rank of the motifs is represented by two values––the first one for the rank of the cluster of similar motifs, the second one is between brackets and represents the rank of the specific motif. (d) Distributions of AUC scores for a given input across all features in the selected databases (marked in purple in tables (c)) with an arrow indicating the top feature within that database. (e) The recovery curves for the top ranked features within the database, where the leading edge (LE) indicates the number of highly ranked target regions. (f) UCSC genome browser screenshot representing an example of one direct target region (red arrowhead) in the intron of gene APOH, which is included in the set of downregulated genes. This region was predicted as a target of EWS-FLI1 in i-cisTarget analyses, of the top less active H3K37ac peaks and the top 200 downregulated genes as well as FLI1 ChIP-seq peaks. The specific binding site is represented by a cluster of EWS-FLI1 motifs (green arrowhead), which was generated by i-cisTarget subsequent analysis, when the predicted target regions of EWS-FLI1 were scanned for CRMs of this factor. All these tracks are represented on the screenshot (from top to bottom): the CRRs, the predicted cluster of EWS-FLI1 motifs, RNA-seq peaks in SK-N-MC and A673 after shFLI1 (two purple tracks, published in (35)) and control (two orange tracks, published in (35)), H3K27ac peaks in SK-N-MC and MSC cell lines expressing EWS-FLI1 (green tracks, published in (35)), FLI1 ChIP-seq track in SK-N-MC and A673 cell lines (blue tracks, published in (35)) as well as DHS on SK-N-MC which was found as the top track within non-TF regulatory tracks (black track, from ENCODE database (15)).
Figure 2. Ewing sarcoma case study. Various i-cisTarget analyses with different types of input, all related to EWS-FLI1 targets in Ewing sarcoma. (a) All input datasets are derived from Riggi et al. (35) and include FLI1 ChIP-seq peaks, top differentially less active peaks based on H3K27ac ChIP-seq upon EWS-FLI1 knockdown, differentially more open regions based on ATAC-seq after EWS-FLI1 activation and differentially downregulated genes after EWS-FLI1 knockdown (see ‘Materials and Methods’ section). (b) Input regions are automatically mapped to CRRs. (c). Each of the sets was analysed independently and reassuringly the expected motif EWS-FLI1 was ranked at the top, alongside regulatory tracks, mainly obtained on the SK-N-MC Ewing sarcoma cell line. Note that the rank of the motifs is represented by two values––the first one for the rank of the cluster of similar motifs, the second one is between brackets and represents the rank of the specific motif. (d) Distributions of AUC scores for a given input across all features in the selected databases (marked in purple in tables (c)) with an arrow indicating the top feature within that database. (e) The recovery curves for the top ranked features within the database, where the leading edge (LE) indicates the number of highly ranked target regions. (f) UCSC genome browser screenshot representing an example of one direct target region (red arrowhead) in the intron of gene APOH, which is included in the set of downregulated genes. This region was predicted as a target of EWS-FLI1 in i-cisTarget analyses, of the top less active H3K37ac peaks and the top 200 downregulated genes as well as FLI1 ChIP-seq peaks. The specific binding site is represented by a cluster of EWS-FLI1 motifs (green arrowhead), which was generated by i-cisTarget subsequent analysis, when the predicted target regions of EWS-FLI1 were scanned for CRMs of this factor. All these tracks are represented on the screenshot (from top to bottom): the CRRs, the predicted cluster of EWS-FLI1 motifs, RNA-seq peaks in SK-N-MC and A673 after shFLI1 (two purple tracks, published in (35)) and control (two orange tracks, published in (35)), H3K27ac peaks in SK-N-MC and MSC cell lines expressing EWS-FLI1 (green tracks, published in (35)), FLI1 ChIP-seq track in SK-N-MC and A673 cell lines (blue tracks, published in (35)) as well as DHS on SK-N-MC which was found as the top track within non-TF regulatory tracks (black track, from ENCODE database (15)).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 43 references

Cited by

Metadata

Authors
Imrichová, H., Hulselmans, G., Kalender Atak, Z., Potier, D., & Aerts, S.
Affiliations
KU Leuven (BE)
Corresponding author
Aerts, Stein
Venue
Nucleic Acids Research
Published
2015-04-29
Volume
43
Issue
W1
Pages
W57-W64
ISSN
  • 0305-1048 (ISSN-L)
  • 1362-4962
OpenAlex
W1977896930
Cited by
202
References
43
Citations by year
2026: 17 · 2025: 16 · 2024: 16 · 2023: 30 · 2022: 24 · 2021: 20 · 2020: 25 · 2019: 19 · 2018: 14 · 2017: 10 · 2016: 6 · 2015: 5
FWCI
5.06
Type
journal article
Language
en
Open access
Locations
  • Nucleic Acids Research (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Lirias (KU Leuven) (submittedVersion, other-oa)
Funders
  • Fonds Wetenschappelijk Onderzoek (G.0791.14, G.0640.13)
  • KU Leuven (PF/10/016, OT/13/103)
  • Kom op tegen Kanker
  • Fondation contre le Cancer (2012-F2)
  • Stand Up To Cancer
  • Bijzonder Onderzoeksfonds UGent (PF/10/016)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
Keywords
enhancer regulation, transcription factor binding motifs, ChIP-seq peaks, histone modifications, open chromatin, Ewing sarcoma, EWS-FLI1, H3K27ac, co-regulated genes, web-based tool
MeSH terms
Animals, Binding Sites, Bone Neoplasms, Drosophila, Enhancer Elements, Genetic, Humans, Sarcoma, Ewing, Software, Transcription Factors, Sequence Analysis, DNA, Internet, Gene Expression Profiling, Genomics, Chromatin Immunoprecipitation, Regulatory Elements, Transcriptional, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.